Peritoneal Mesothelioma: Symptoms, Diagnosis and Treatment
Author: Ian C. Langtree - View Credentials
Published: 9 Oct 2010 - Updated: 1 Oct 2026
Publication Type: Informative
Table of Contents:
Synopsis - Definition - Overview - FAQs - Insights, Updates - Related Content
Synopsis
This information covers peritoneal mesothelioma, a rare and aggressive cancer of the abdominal lining that is strongly tied to asbestos exposure and may not appear until many years after contact with the fibers. It sets out the main symptoms - weight loss, abdominal swelling and pain caused by fluid buildup, along with bowel obstruction, anemia and fever - and explains why the disease is so often mistaken for other conditions before CT or MRI imaging raises suspicion. The material is useful because it puts clinical terms into plain language for people who worked around asbestos, their families and caregivers. It is of particular relevance to seniors, since the long delay between exposure and illness means most diagnoses come later in life, and to people with disabilities or chronic illness who are weighing care and benefit options.
At a Glance
- 1 - Fluid drained by paracentesis has limited diagnostic value, so a tissue biopsy is normally needed to confirm the disease.
- 2 - People who live with asbestos workers also carry a higher risk, most likely from dust brought home on work clothing and hair.
- 3 - The U.S. Social Security Administration lists peritoneal mesothelioma as a Compassionate Allowance condition, which speeds up the handling of disability claims.
- 4 - Doctors separate two clinical forms on CT scans. The dry type shows one dominant mass or several tiny masses with little or no fluid, while the wet type shows widespread small nodules with ascites.
Topic Definition
- Peritoneal Mesothelioma
Peritoneal mesothelioma is a rare cancer that begins in the mesothelial cells of the peritoneum, the thin membrane that lines the abdominal cavity and covers organs such as the stomach, liver and intestines. It is most often linked to past asbestos exposure, with the disease typically surfacing decades after the fibers were inhaled or swallowed. As tumors spread across the peritoneal surface they commonly cause fluid buildup, abdominal swelling, pain and weight loss, and a tissue biopsy is needed to confirm the diagnosis. It is the second most common form of mesothelioma after the pleural type, which affects the lining of the lungs.
Overview
Peritoneal mesothelioma is a rare cancer that forms in the peritoneum, the thin membrane that lines the abdominal cavity and covers most of the abdominal organs. It accounts for roughly 15 percent of all mesothelioma cases, with an estimated 300 to 400 people diagnosed in the United States each year [National Comprehensive Cancer Network, 2023]. Unlike the pleural form, which affects men far more often, peritoneal mesothelioma occurs in men and women in about equal numbers.
Causes and Risk Factors
Asbestos exposure is the best established cause, although the link is weaker than it is for pleural mesothelioma and a notable share of patients have no known exposure. How the fibers reach the abdomen remains unresolved. It has been proposed that asbestos fibers from the lung are carried to the abdomen and associated organs through the lymphatic system, or that fibers are deposited in the gut after a person swallows contaminated sputum.
The disease can appear decades after exposure, typically 20 to 50 years later. There is evidence that family members and others living with people exposed to asbestos have an increased risk of developing mesothelioma and possibly other asbestos-related diseases. This risk may result from asbestos dust brought home on the clothing and hair of asbestos workers.
Genetics also play a part. Inherited mutations in the BAP1 gene raise the risk of mesothelioma and several other cancers, and ALK gene rearrangements have been identified in some younger patients with no history of asbestos exposure [National Comprehensive Cancer Network, 2023].
Types of Peritoneal Mesothelioma
Peritoneal mesothelioma has two clinical types that can be told apart on CT scans. It is classified as "dry" when there are multiple tiny masses or one dominant localized mass and generally little or no ascites. The "wet" type has widespread small nodules, no dominant mass, and ascites present.
Pathologists also group tumors by cell type, which strongly influences treatment choices and outlook:
- Epithelioid - the most common type, and the one that responds best to treatment.
- Sarcomatoid - less common and more aggressive.
- Biphasic - a mixture of epithelioid and sarcomatoid cells.
Symptoms
The most common presenting signs are ascites, a buildup of fluid in the abdominal cavity, found in about 77 percent of patients, abdominal pain in about 69 percent, and a detectable abdominal mass in about 30 percent [National Comprehensive Cancer Network, 2023]. Abdominal swelling or distension, weight loss and cachexia are also frequent.
Other symptoms may include bowel obstruction, blood clotting abnormalities, anemia, and fever. Because these symptoms are nonspecific and overlap with many more common conditions, the disease is often advanced by the time it is identified.
Diagnosis
Diagnosing peritoneal mesothelioma is often difficult because the symptoms are commonly associated with other conditions. Evaluation begins with a review of the patient's medical history, including any past asbestos exposure, and a complete physical examination. Contrast-enhanced CT of the chest, abdomen and pelvis is the standard imaging test, with MRI used in some cases.
Imaging can suggest the disease but cannot confirm it. If fluid is present it can be drained by paracentesis, but analysis of this fluid has limited diagnostic value. A definitive diagnosis requires a tissue biopsy, most often taken during laparoscopy, which current guidelines prefer over fluid cytology alone [Brown et al., 2025].
The biopsy sample is examined with immunohistochemistry, using markers such as calretinin, podoplanin (D2-40) and BAP1, to separate mesothelioma from ovarian, gastrointestinal and other cancers that can look similar. Blood markers such as soluble mesothelin-related peptide and CA-125 may support the assessment and help with monitoring, but they cannot establish the diagnosis on their own.
Treatment
Treatment is best planned by a multidisciplinary team at a center experienced in peritoneal surface cancers. The approach depends on how far the disease has spread, the cell type, and the patient's overall health.
Surgery With Heated Chemotherapy
For eligible patients, the standard of care is cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy, known as HIPEC. Surgeons remove all visible tumor from the abdomen, which may involve removing parts of several organs, and then circulate heated chemotherapy, usually cisplatin-based, through the abdominal cavity to reach remaining cancer cells. The best candidates have disease confined to the abdomen, epithelioid cell type, and are fit enough for major surgery. The goal is complete removal of visible disease [Brown et al., 2025].
Systemic Therapy
Patients who are not candidates for surgery are generally treated with drug therapy. First-line options include pemetrexed combined with cisplatin or carboplatin, sometimes with bevacizumab added, or the immunotherapy combination of nivolumab and ipilimumab. Immunotherapy is the preferred first choice for biphasic and sarcomatoid tumors [Tanvetyanon and Simon, 2024]. Much of the evidence for these drugs comes from trials in pleural mesothelioma, since the peritoneal form is too rare for large dedicated studies.
Supportive Care
Draining ascites, managing pain, and nutritional support are important at every stage, and palliative care can be provided alongside active treatment.
Prognosis
Delayed diagnosis worsens the outlook, and cure remains rare. Historically, most studies reported a median survival of less than a year. Across all patients today, one-year survival is about 46 percent and five-year survival is about 20 percent [National Comprehensive Cancer Network, 2023].
Results are considerably better for people able to have cytoreductive surgery with HIPEC. A pooled analysis of 1,047 patients treated this way found survival of 84 percent at one year, 59 percent at three years, and 42 percent at five years [National Comprehensive Cancer Network, 2023]. Epithelioid tumors carry a better prognosis than biphasic or sarcomatoid tumors.
After treatment, follow-up imaging is recommended every three months for the first two years, every six months in years three and four, and annually after that [Brown et al., 2025].
Disability Benefits
The U.S. Social Security Administration (SSA) includes peritoneal mesothelioma on its Compassionate Allowances list, which fast-tracks disability claims for conditions that clearly meet the agency's standards.
Frequently Asked Questions
How long after asbestos exposure does peritoneal mesothelioma usually appear?
The latency period is long, typically 20 to 50 years between first exposure and diagnosis. This is why most people are diagnosed in middle age or later, often well after leaving the job where the exposure took place.
What is HIPEC and how is it used for peritoneal mesothelioma?
HIPEC stands for hyperthermic intraperitoneal chemotherapy. After surgeons remove all visible tumor in an operation called cytoreductive surgery, heated chemotherapy is circulated through the abdomen to reach remaining cancer cells. In carefully selected patients treated at specialist centers, this combined approach has been associated with median survival of several years.
How common is peritoneal mesothelioma?
It is very rare. Mesothelioma of all types accounts for roughly 3,000 new cases a year in the United States, and the peritoneal form makes up a minority of these, amounting to a few hundred cases annually.
How is peritoneal mesothelioma different from pleural mesothelioma?
Both begin in mesothelial cells, but pleural mesothelioma forms in the lining around the lungs and causes chest pain, breathlessness and cough, while peritoneal mesothelioma forms in the abdominal lining and causes swelling, pain and digestive problems. The pleural form is far more common, and the two are assessed and treated differently.
Can peritoneal mesothelioma run in families?
Most cases are not inherited, but a small number are linked to inherited changes in a gene called BAP1, which raise the risk of mesothelioma and certain other cancers. People with several affected relatives may be offered genetic counseling.
What are the cell types of peritoneal mesothelioma?
Pathologists classify tumors as epithelioid, sarcomatoid or biphasic, which is a mix of the two. Epithelioid is the most common type in the peritoneum and generally responds best to treatment, while sarcomatoid tumors tend to be more aggressive.
Can peritoneal mesothelioma occur without known asbestos exposure?
Yes. A meaningful share of people diagnosed with the peritoneal form, particularly women, have no identifiable asbestos exposure. Other factors under study include the mineral erionite, previous radiation to the abdomen, and inherited gene changes.
What financial help is available for people with peritoneal mesothelioma besides Social Security disability?
Depending on circumstances, options in the United States may include claims against asbestos bankruptcy trust funds, workers compensation, legal action against manufacturers, and Department of Veterans Affairs benefits for those exposed during military service. Rules and deadlines vary by state, so advice from a qualified attorney or benefits counselor is worthwhile.
References
- Brown, L. M., Wilkins, S. G., Bansal, V. V., et al. (2025). Consensus guideline for the management of peritoneal mesothelioma. Cancer.
- National Comprehensive Cancer Network. (2023). Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 21(9), 961.
- Tanvetyanon, T., and Simon, G. R. (2024). Systemic therapy options for peritoneal mesothelioma. Journal of the National Comprehensive Cancer Network, 22(8).
- U.S. Social Security Administration. Compassionate Allowances - Complete List of Conditions.
Insights, Analysis, and Developments
Editorial Note: Much about peritoneal mesothelioma is still not settled, including exactly how asbestos fibers reach the abdomen - the leading ideas are that they travel from the lungs through the lymphatic system or are swallowed in contaminated sputum. What is clear is that timing matters: a delayed diagnosis worsens the outlook, while surgical removal of as much tumor as possible is linked to better results and should be attempted when feasible, with chemotherapy given systemically or directly into the abdomen to help control symptoms. For anyone with a history of asbestos work, or who shared a home with someone who had one, persistent abdominal symptoms deserve prompt attention and a frank conversation with a doctor about that exposure history, because the years between contact and illness make the connection easy to miss.
Author Credentials: Ian C. Langtree is a writer, editor, and the founder and Editor-in-Chief of Disabled World, which he established in 2004 as one of the longest-running independent resources for disability news and information. Over more than two decades, he has written and edited thousands of articles on disability rights, health, accessibility, and assistive technology. Drawing on a global perspective shaped by extensive travel and lived experience, Ian is a committed advocate of the Social Model of Disability, the framework developed by disabled activists in the 1970s that focuses on removing societal barriers rather than on individual impairments. His writing is grounded in that framework and in a lasting commitment to disability rights, accessibility, and social inclusion. To learn more about Ian's background, expertise, and accomplishments, visit his full biography.